Diagnostic Technologies: Page 4

Gene-based technique shows potential for rapid diagnostics

By LabPulse.com staff writers

Biomedical engineers have developed a new gene-based approach which can be used on test strips for rapid, on-the-spot disease detection with accuracy comparable to that of lab-based polymerase chain reaction (PCR) tests.

March 7, 2024

Ibex, PathPresenter ink partnership

By LabPulse.com staff writers

Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to enable wider use of AI-enabled digital pathology for their joint customers.

March 6, 2024

FDA LDT oversight battle: Are we close?

By Liz Carey

New directions in laboratory developed test (LDT) regulation appeared closer to final rule-making with the March 1 Office of Management and Budget (OMB) acceptance of the LDT final rule, pending regulatory review: a flurry of final rule-making thoughts.

March 6, 2024

AMDI receives $5.2M in RADx Tech funding for PCR viral testing system

By LabPulse.com staff writers

Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.

March 4, 2024

Reversible, multiplex CRISPR system enhances efficacy of CAR-T cell therapy

By Nick Paul Taylor

A CRISPR system that uses Cas13d to make reversible changes to the expression of multiple genes could overcome limitations that are holding back CAR-T cell therapies, a paper published in Cell suggests.

February 28, 2024

Alamar Biosciences raises $100M in series C financing round

By LabPulse.com staff writers

Precision proteomics company Alamar Biosciences has raised $100 million in an oversubscribed series C financing round, with a second close of an additional $28 million anticipated within the next 30 days.

February 27, 2024

CAP releases updated guideline for validation of IHC assays

By LabPulse.com staff writers

The College of American Pathologists (CAP) has updated its evidence-based guideline for analytic validation of immunohistochemical assays to provide increased accuracy and consistency in laboratory practices.

February 26, 2024

EnsoData’s AI-powered sleep study diagnostic gets FDA 510(k) clearance

By LabPulse.com staff writers

EnsoData has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its machine learning-based diagnostic for sleep apnea and other sleep disorders that uses data from pulse oximetry devices.

February 26, 2024

Intellia Therapeutics, ReCode Therapeutics to collaborate on genomic medicines for CF

By LabPulse.com staff writers

Gene-editing firm Intellia Therapeutics and biotech company ReCode Therapeutics have entered into a strategic collaboration aimed at developing genomic medicines for the treatment of cystic fibrosis (CF).

February 16, 2024

CRISPR and nanopore technology enable sensitive and specific mpox detection

By Nick Paul Taylor

A test that combines CRISPR gene editing and nanopore sensing technology could accelerate the detection of mpox and other pathogens, according to a paper published in Biosensors and Bioelectronics.

February 16, 2024

Gold-enhanced nanopore sensors detect ovarian cancer biomarker in urine

By Nick Paul Taylor

Nanopore sensors that use gold nanoparticles to capture certain peptides could enable the detection of ovarian cancer biomarkers in urine samples, according to a paper published in ACS Sensors.

February 14, 2024

Proscia receives 510(k) clearance from FDA for digital pathology solution

By Matt Limb

Software company Proscia has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital pathology solution, Concentriq AP-Dx.

February 12, 2024

Previous Page

Page 4 of 311

Next Page